Share
print this page decrease the text size increase the text size

Advisory Committee on Complementary Medicines (ACCM)

16 May 2013

Role of ACCM

The Advisory Committee on Complementary Medicines (ACCM) was formed in January 2010 to advise and make recommendations to the Therapeutic Goods Administration (TGA) on the inclusion, variation or retention of a complementary medicine in the Australian Register of Therapeutic Goods.

ACCM may also provide advice to the TGA on any other matters concerning complementary medicines, and any other matters referred to it by the TGA (whether or not related to a complementary medicine).

ACCM supersedes the Complementary Medicines Evaluation Committee (CMEC) and has an increased focus on the advisory role within the regulatory framework of complementary medicines.

A major role for ACCM is to provide scientific and policy advice relating to controls on the supply and use of complementary medicines in Australia. The ACCM provides this advice with particular reference to the safety and quality of products and, where appropriate, efficacy relating to the claims made for products.

ACCM members

Chair

Professor Alan Bensoussan is the Director, Centre for Complementary Medicine Research, University of Western Sydney and Executive Director, National Institute of Complementary Medicine Australia. He has been in clinical practice for over 25 years and is an active researcher. Professor Bensoussan has been a lead investigator on many high quality clinical trials of Chinese medicine, resulting in numerous publications in peer-reviewed journals. As such he brings methodological experience in clinical investigation of Chinese medicines, including chemical definitions of products, safety and efficacy assessments, contrasting diagnostic approaches and labelling of illness in traditional medicine. Professor Bensoussan provides expertise in the field of complementary medical practice.

Members

ACCM meeting dates

ACCM meetings 2013

Meeting date Venue
1 March 2013 Canberra
14 June 2013 Melbourne (cancelled)
2 August 2013 Melbourne
6 September 2013 Canberra (cancelled)
6 December 2013 Sydney

Contacting ACCM

To contact the ACCM Secretariat:

Email accm@tga.gov.au
Phone

+61 2 6232 8734

Fax +61 2 6203 1250
Postal address

Advisory Committee on Complementary Medicines
Therapeutic Goods Administration
PO Box 100 (MDP 122)
Woden ACT 2606
Australia

Top of page

Content last updated: Thursday, 16 May 2013

Content last reviewed: Thursday, 16 May 2013

Web page last updated: Monday, 20 May 2013

URL: http://www.tga.gov.au/about/committees-accm.htm

Site navigation

Safety information

Consumers

Health professionals

Industry

About the TGA

News room